Navigation Links
Matuzumab in Medical News

Merck and Takeda to collaborate in the sale of Cancer drug Matuzumab

Merck Pharmaceuticals from Germany and Takeda Pharmaceuticals from Japan to colloborate in marketing of Merck's cancer drug Matuzumab. Matuzumab is developed by Merck which is in its Phase II // clinical tiral. Takeda Pharmaceuticals will sign agreement with Merck to give royalty and sale be...

Double binding sites on tumor target may provide future combination therapy

...r other types of cancer. An additional drug called matuzumab is in phase II clinical trials. Three years ago...s found again using X-ray crystallography -- that matuzumab binds in a different place from Erbitux. Their bin...has important implications for the clinical use of matuzumab and for developing new therapies that target EGFR....
Matuzumab in Medical Technology

ImClone Systems Showcases Extensive Research and Development Program at the AACR Annual Meeting

...fferent anti-EGFR agents, including other monoclonal antibodies, have different biological effects. (#336 Meira et al. Differences in activity between matuzumab and cetuximab in A431 cells may rely on MAPK cascade inhibition.) -- Emerging biomarkers may serve as predictors of clinical response to ERBITUX. (#...
Matuzumab in other areas

Matuzumab - Wikipedia, the free encyclopedia

Matuzumab is a humanized monoclonal antibody for the treatment of cancer. It binds to EGFR with high affinity.

Matuzumab (EMD72000)

... please contact the site administrator at: matuzumab@emdpharmaceuticals.com. Matuzumab is currently under clinical investigation and has not been approved ...

Definition of matuzumab - National Cancer Institute Drug Dictionary

matuzumab. A humanized monoclonal antibody with antineoplastic activity. Matuzumab binds the epidermal growth factor receptor (EGFR) with high affinity, ...

Definition of matuzumab - NCI Dictionary of Cancer Terms

matuzumab. A monoclonal antibody that is being studied in the treatment of ... Matuzumab binds to the epithelial growth factor receptor (EGFR) on tumor cells ...

Matuzumab facts - Freebase

Facts and figures about Matuzumab, taken from Freebase, the world's database. ... If you know more about Matuzumab, you can add more facts here " ...

Merck KGaA 'reconsidering' further development of Matuzumab in ...

FRANKFURT (Thomson Financial) - Merck KGaA said its division Merck Serono's Phase II trial of Matuzumab to treat metastatic colorectal cancer (mCRC) did not meet its ...
Other Tags
(Date:6/18/2013)... have discovered and mapped the signaling network between two ... could cut off cancer cell growth at its starting ... University of Texas MD Anderson Cancer Center reported the ... cancer drug target, and MCM7, a protein vital to ... issue of Cancer Cell . , "MCM7 overexpression ...
(Date:6/18/2013)... Two months ago, Suyima Torres, 28, died ... second session of a silicone treatment for gluteus augmentation at ... allegedly performed by a mystery Venezuelan doctor in a center ... Dr. Bernabe Vazquez of Bayshore Cosmetic Surgery , women ... who are not board certified is more common than people ...
(Date:6/18/2013)... June 18, 2013 David Connett, DO, ... Family Medicine for the College of Osteopathic Medicine of ... has been elected president of the Osteopathic Medical ... Brown Jr. appointed Connett, a 1984 alumnus of COMP, ... recently elected Connett to the position during a conference ...
(Date:6/18/2013)... keep their scheduled medical appointments and their disease ... explains things clearly and knows them as a person, ... , "If people feel their doctor really knows them ... their best interests at heart and may be more ... E. Flickinger, M.D., M.P.H., a fellow in the Division ...
(Date:6/18/2013)... NEW YORK (June 18, 2013)-- An international team of ... a new framework for evidence-based surgery and device research, ... used in evidence-based medicine. , "Currently, there is no ... that don,t offer any benefits to patients or may ... of Weill Cornell Medical College. , In the ...
Breaking Medicine News(10 mins):Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 2Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 3Health News:Respect may be the key to stopping patient 'no shows' 2Health News:Tackling a framework for surgical innovation 2Health News:Tackling a framework for surgical innovation 3
(Date:6/18/2013)... It is estimated that between 5% and 10% of ... is to say that these tumours are attributable to ... BRCA1 or BRCA2. In patients with these mutations, PARP ... encouraging results that make them a new option for ... the latest studies indicate that a fraction of these ...
(Date:6/18/2013)... LA, London (18 June 2013). A team of internationally ... by Dr Sarah Ellis from the University of Lincoln, ... Clinic, Wisconsin, U.S.A. were invited by the International Society ... Feline Practitioners (AAFP) to compile guidelines for veterinarians, owners ... the environmental needs of the domestic cat. The new ...
(Date:6/17/2013)... MA Women in the U.S. exposed to high levels ... likely to have a child with autism as women who ... study from Harvard School of Public Health (HSPH). It is ... and air pollution across the U.S. , "Our findings raise ... the women in our study lived in areas where risk ...
Breaking Biology News(10 mins):An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2Feline behavior experts release guidelines to improve the welfare of cats 2Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2
Other Contents